Dick de Zeeuw

Bekijk Scopus-profiel

Als u wijzigingen in Pure hebt gemaakt, zullen deze hier binnenkort zichtbaar zijn.

Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
CREDENCE Trial Investigators, Yi, T. W., Smyth, B., Di Tanna, G. L., Arnott, C., Cardoza, K., Kang, A., Pollock, C., Agarwal, R., Bakris, G., Charytan, D. M., de Zeeuw, D., Heerspink, H. J. L., Neal, B., Wheeler, D. C., Cannon, C. P., Zhang, H., Zinman, B., Perkovic, V., Levin, A., & 2 anderenMahaffey, K. W. & Jardine, M. J., jul.-2023, In: American Journal of Kidney Diseases. 82, 1, blz. 84-96.e1 14 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

2 Downloads (Pure)
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study
Mark, P. B., Carrero, J. J., Matsushita, K., Sang, Y., Ballew, S. H., Grams, M. E., Coresh, J., Surapaneni, A., Brunskill, N. J., Chalmers, J., Chan, L., Chang, A. R., Chinnadurai, R., Chodick, G., Cirillo, M., de Zeeuw, D., Evans, M., Garg, A. X., Gutierrez, O. M., Heerspink, H. J. L., & 28 anderenHeine, G. H., Herrington, W. G., Ishigami, J., Kronenberg, F., Lee, J. Y., Levin, A., Major, R. W., Marks, A., Nadkarni, G. N., Naimark, D. M. J., Nowak, C., Rahman, M., Sabanayagam, C., Sarnak, M., Sawhney, S., Schneider, M. P., Shalev, V., Shin, J. I., Siddiqui, M. K., Stempniewicz, N., Sumida, K., Valdivielso, J. M., van den Brand, J., Yee-Moon Wang, A., Wheeler, D. C., Zhang, L., Visseren, F. L. J. & Stengel, B., 1-apr.-2023, In: European Heart Journal. 44, 13, blz. 1157-1166 10 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

3 Citaten (Scopus)
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease
Waijer, S. W., Sen, T., Arnott, C., Neal, B., Kosterink, J. G. W., Mahaffey, K., Parikh, C., de Zeeuw, D., Perkovic, V., Neuen, B. L., Coca, S. G., Hansen, M. K., Gansevoort, R. T. & Heerspink, H. J. L., 1-feb.-2022, In: Clinical Journal of the American Society of Nephrology. 17, 2, blz. 251-259 9 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

9 Citaten (Scopus)

116 Downloads (Pure)
Canagliflozin Reduces Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial
Heerspink, H. J. L., Oshima, M., Zhang, H., Li, J., Agarwal, R., Capuano, G., Charytan, D. M., Craig, J., de Zeeuw, D., Di Tanna, G. L., Levin, A., Neal, B., Perkovic, V., Wheeler, D. C., Yavin, Y. & Jardine, M. J., feb.-2022, In: American Journal of Kidney Diseases. 79, 2, blz. Pages 244-256.e1 12 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

17 Citaten (Scopus)

95 Downloads (Pure)
Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial
Li, J. W., Arnott, C., Heerspink, H. J. L., Mbiostat, Q. L., Cannon, C. P., Wheeler, D. C., Charytan, D. M., Barraclough, J., Figtree, G. A., Agarwal, R., Bakris, G., de Zeeuw, D., Greene, T., Levin, A., Pollock, C., Zhang, H., Zinman, B., Mahaffey, K. W., Perkovic, V., Neal, B., & 1 anderenJardine, M. J., 16-aug.-2022, In: Journal of the American Heart Association. 11, 16, 16 blz., e025045.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

8 Downloads (Pure)

Supplementary Material for: Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy
Usiskin, K. (Contributor), Bakris, G. (Contributor), Mayer, C. (Contributor), Meininger, G. (Contributor), Kline, I. (Contributor), Vijapurkar, U. (Contributor), Davies, M. (Contributor), Woo, V. (Contributor), Perkovic, V. (Contributor), Yamout, H. (Contributor) & de Zeeuw, D. (Contributor), University of Groningen, 20-jun.-2017
DOI: 10.6084/m9.figshare.5126725.v1, https://doi.org/10.6084%2Fm9.figshare.5126725.v1
Dataset
Additional file 1 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Lienczewski, C. (Contributor), Karihaloo, A. (Contributor), Kretzler, M. (Contributor), Dutius Andersson, A. (Contributor), Pontrelli, P. (Contributor), Gesualdo, L. (Contributor), Sharma, K. (Contributor), Welberry Smith, M. (Contributor), Gooding, K. M. (Contributor), Shore, A. C. (Contributor), Ibberson, M. (Contributor), Lambers Heerspink, H. (Contributor), Gomez, M. F. (Contributor), Gilchrist, M. (Contributor), Nuutila, P. (Contributor), Teh, I. (Contributor), Mansfield, M. (Contributor), Papale, M. (Contributor), Banks, R. E. (Contributor), Bailey, J. (Contributor), Andress, D. (Contributor), Koivuviita, N. (Contributor), Sourbron, S. (Contributor), Tobin, K. (Contributor), Metsärinne, K. (Contributor), Zetterqvist, A. (Contributor), Garcia Hernandez, A. (Contributor), de Zeeuw, D. (Contributor), Ball, C. (Contributor), Grenier, N. (Contributor), Saunavaara, V. (Contributor), Maziarz, M. (Contributor), Gilmour, P. S. (Contributor), Shelley, D. (Contributor) & Puppala, S. (Contributor), University of Groningen, 29-jun.-2020
DOI: 10.6084/m9.figshare.12586625.v1
Dataset
Additional file 2 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Dutius Andersson, A. (Contributor), Garcia Hernandez, A. (Contributor), Tobin, K. (Contributor), Ball, C. (Contributor), Saunavaara, V. (Contributor), Teh, I. (Contributor), Banks, R. E. (Contributor), Sharma, K. (Contributor), Lienczewski, C. (Contributor), Koivuviita, N. (Contributor), Metsärinne, K. (Contributor), de Zeeuw, D. (Contributor), Karihaloo, A. (Contributor), Mansfield, M. (Contributor), Lambers Heerspink, H. (Contributor), Maziarz, M. (Contributor), Gesualdo, L. (Contributor), Pontrelli, P. (Contributor), Bailey, J. (Contributor), Papale, M. (Contributor), Nuutila, P. (Contributor), Gomez, M. F. (Contributor), Ibberson, M. (Contributor), Gooding, K. M. (Contributor), Sourbron, S. (Contributor), Shelley, D. (Contributor), Grenier, N. (Contributor), Shore, A. C. (Contributor), Zetterqvist, A. (Contributor), Welberry Smith, M. (Contributor), Gilchrist, M. (Contributor), Kretzler, M. (Contributor), Gilmour, P. S. (Contributor), Puppala, S. (Contributor) & Andress, D. (Contributor), University of Groningen, 29-jun.-2020
DOI: 10.6084/m9.figshare.12586628.v1
Dataset
Supplementary Material for: A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics
Eder, S. (Contributor), Leierer, J. (Contributor), Kerschbaum, J. (Contributor), Rosivall, L. (Contributor), Wiecek, A. (Contributor), de Zeeuw, D. (Contributor), Mark, P. B. (Contributor), Heinze, G. (Contributor), Rossing, P. (Contributor), Lambers Heerspink, H. (Contributor) & Mayer, G. (Contributor), University of Groningen, 21-feb.-2018
DOI: 10.6084/m9.figshare.5909164.v1
Dataset
Additional file 4 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Pontrelli, P. (Contributor), Grenier, N. (Contributor), Sharma, K. (Contributor), Dutius Andersson, A. (Contributor), Garcia Hernandez, A. (Contributor), Mansfield, M. (Contributor), Teh, I. (Contributor), de Zeeuw, D. (Contributor), Lambers Heerspink, H. (Contributor), Ibberson, M. (Contributor), Papale, M. (Contributor), Saunavaara, V. (Contributor), Shore, A. C. (Contributor), Koivuviita, N. (Contributor), Sourbron, S. (Contributor), Bailey, J. (Contributor), Andress, D. (Contributor), Lienczewski, C. (Contributor), Banks, R. E. (Contributor), Metsärinne, K. (Contributor), Gilmour, P. S. (Contributor), Maziarz, M. (Contributor), Tobin, K. (Contributor), Shelley, D. (Contributor), Gesualdo, L. (Contributor), Puppala, S. (Contributor), Kretzler, M. (Contributor), Welberry Smith, M. (Contributor), Gooding, K. M. (Contributor), Nuutila, P. (Contributor), Gilchrist, M. (Contributor), Karihaloo, A. (Contributor), Ball, C. (Contributor), Zetterqvist, A. (Contributor) & Gomez, M. F. (Contributor), University of Groningen, 29-jun.-2020
DOI: 10.6084/m9.figshare.12586637.v1
Dataset

Dick de Zeeuw

Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar

Duik in details

Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study

Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease

Canagliflozin Reduces Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial

Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

Supplementary Material for: Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy

Additional file 1 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol

Additional file 2 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol

Supplementary Material for: A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics

Additional file 4 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol

Dick de Zeeuw

Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar

Onderzoeksoutput

Datasets